Finland· FI-REL-REL47110
Biseltoc
A pentoxyverine product containing pentoxyverine citrate, registered in Finland by Opella Healthcare France SAS. The same ATC class is registered in 6 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Pentoxyverine is registered in 6 of 19 countries.
Countries holding a registration under ATC R05DB05 (pentoxyverine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Pentoxyverine · ATC R05DB05
6 / 19 countries
- Belgiumprice
- Finlandprice
- Franceprice
- Germany
- Japan
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Pentoxyverine citrate
- Manufacturer
- Opella Healthcare France SAS
- Country
- Finland (FI)
- ATC code
- R05DB05
- ATC class
- Pentoxyverine
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
260 interactions on record for pentoxyverine.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pentoxyverine · interactions on record
260 records
- 7 severe
- 253 moderate
Most severe, free to view
- ProcarbazineL01XB01severe
- SelegilineN04BD01severe
- RasagilineN04BD02severe
- SafinamideN04BD03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pentoxyverine in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBalsoclase Antitussivum 2.13 mg/mlPierre Fabre Médicament
- SpainBISOLVON CALMATOS 2,13 MG/ML SOLUCION ORALOpella Healthcare Spain S.L.
- SwedenBiseltoc 2,13 mg/ml Oral lösningOpella Healthcare France SAS
- GermanyPentoxyverin AlAliud Pharma Gmbh
- FrancePENTOXYVERINE CLARIX 0,15 % ADULTES, siropCOOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- SwitzerlandBisolvon Pentoxyverin 2.13 mg/ml, SirupOpella Healthcare Switzerland AG
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Mucomat Hustenstiller
- Belgium · Pentoxyverine Sanofi, Pentoxyvérine Sanofi
- Germany · Pentoxyverin Al, Sedotussin Hustenstiller
- Spain · Bisolvon Calmatos
- France · Clarix Adultes Édulcorée Au Maltitol Liquide, Clarix Enfants
- Italy · Pentοssiverina Opella Healthcare
- Luxembourg · Pentoxyvérine Sanofi
- Norway · Biseltoc
- Portugal · Bisoltussin
- Sweden · Biseltoc
- Slovakia · Stadatussin, Stadatussin Kvapky
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc297446-03cd-4203-890b-e9e1b2e62e8c GET /v1/drugs/dc297446-03cd-4203-890b-e9e1b2e62e8c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.1",
"form": "oraaliliuos",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "2.13 mg/ml",
"atc_label": "pentoksiveriini",
"ma_number": "33170",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL47110",
"authorised_at": "2016-06-17"
}See everything about pentoxyverine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.